Prolonged activation of the baroreflex abolishes obesity-induced hypertension

被引:99
|
作者
Lohmeier, Thomas E.
Dwyer, Terry M.
Irwin, Eric D.
Rossing, Martin A.
Kieval, Robert S.
机构
[1] Univ Mississippi, Med Ctr, Dept Physiol, Jackson, MS 39216 USA
[2] N Mem Med Ctr, Robbinsdale, MN USA
[3] CVRx Inc, Maple Grov, MN USA
关键词
baroreflex; hypertension; heart rate; obesity; sympathetic nervous system; norepinephrine; renin-angiotensin system;
D O I
10.1161/HYPERTENSIONAHA.107.087874
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Prolonged electrical activation of the carotid baroreflex produces sustained reductions in sympathetic activity and arterial pressure in normotensive dogs. The main goal of this study was to assess the influence of prolonged baroreflex activation on arterial pressure and neurohormonal responses in 6 dogs with obesity-induced hypertension. After control measurements, the diet was supplemented with cooked beef fat for 6 weeks, whereas sodium intake was held constant. After 4 weeks of the high-fat diet, there were increments in body weight from 25.8 +/- 0.7 to 38.6 +/- 1.0 kg, mean arterial pressure from 97 +/- 2 to 110 +/- 3 mm Hg, heart rate from 67 +/- 3 to 91 +/- 4 bpm, and plasma norepinephrine concentration from 141 +/- 35 to 280 +/- 52 pg/mL. Plasma glucose and insulin concentrations were elevated, but increases in plasma renin activity during the initial weeks of the high-fat diet were not sustained. During week 5, baroreflex activation resulted in sustained reductions in mean arterial pressure, heart rate, and plasma norepinephrine concentration; at the end of week 5, these values were 87 +/- 2 mm Hg, 77 +/- 4 bpm, and 166 +/- 45 pg/mL, respectively. These suppressed values returned to week 4 levels during a 7-day recovery period after baroreflex activation. There were no changes in plasma glucose or insulin concentrations, or plasma renin activity during prolonged baroreflex activation. These findings indicate that baroreflex activation can chronically suppress the sympathoexcitation associated with obesity and abolish the attendant hypertension while having no effect on hyperinsulinemia or hyperglycemia.
引用
收藏
页码:1307 / 1314
页数:8
相关论文
共 50 条
  • [41] Baroreflex activation for the treatment of hypertension: principles and practice
    Sica, Domenic A.
    Lohmeier, Thomas E.
    EXPERT REVIEW OF MEDICAL DEVICES, 2006, 3 (05) : 595 - 601
  • [42] Neurons of the rostral ventrolateral medulla contribute to obesity-induced hypertension in rats
    Stocker, Sean D.
    Meador, Rachel
    Adams, Julye M.
    HYPERTENSION, 2007, 49 (03) : 640 - 646
  • [43] Baroreflex activation therapy in hypertension
    Gassler, J. P.
    Bisognano, J. D.
    JOURNAL OF HUMAN HYPERTENSION, 2014, 28 (08) : 469 - 474
  • [44] Baroreflex activation therapy in hypertension
    J P Gassler
    J D Bisognano
    Journal of Human Hypertension, 2014, 28 : 469 - 474
  • [45] Augmented endothelial-specific L-arginine transport prevents obesity-induced hypertension
    Rajapakse, N. W.
    Karim, F.
    Straznicky, N. E.
    Fernandez, S.
    Evans, R. G.
    Head, G. A.
    Kaye, D. M.
    ACTA PHYSIOLOGICA, 2014, 212 (01) : 39 - 48
  • [46] Role of excitatory amino acid input in rostral ventrolateral medulla neurons in rats with obesity-induced hypertension
    Suhaimi, Farah Wahida
    Yusoff, Nurul Hasnida Mohammad
    Dewa, Aidiahmad
    Yusof, Ahmad Pauzi M. D.
    ACTA NEUROLOGICA BELGICA, 2010, 110 (01) : 57 - 64
  • [47] Sex differences in obesity-induced hypertension and vascular dysfunction: a protective role for estrogen in adipose tissue inflammation?
    Taylor, Lia E.
    Sullivan, Jennifer C.
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY, INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2016, 311 (04) : R714 - R720
  • [48] EFFECTS OF CAPTOPRIL ON SYMPATHETIC ACTIVITY, LIPID AND CARBOHYDRATE-METABOLISM IN A MODEL OF OBESITY-INDUCED HYPERTENSION IN DOGS
    ROBLES, RG
    VILLA, E
    SANTIRSO, R
    MARTINEZ, J
    RUILOPE, LM
    CUESTA, C
    SANCHO, JM
    AMERICAN JOURNAL OF HYPERTENSION, 1993, 6 (12) : 1009 - 1015
  • [49] Urolithin A ameliorates obesity-induced metabolic cardiomyopathy in mice via mitophagy activation
    Jian-rong Huang
    Ming-hua Zhang
    Ying-jie Chen
    Yu-ling Sun
    Zhi-min Gao
    Zhuo-jia Li
    Gui-ping Zhang
    Yuan Qin
    Xiao-yan Dai
    Xi-yong Yu
    Xiao-qian Wu
    Acta Pharmacologica Sinica, 2023, 44 : 321 - 331
  • [50] Urolithin A ameliorates obesity-induced metabolic cardiomyopathy in mice via mitophagy activation
    Huang, Jian-rong
    Zhang, Ming-hua
    Chen, Ying-jie
    Sun, Yu-ling
    Gao, Zhi-min
    Li, Zhuo-jia
    Zhang, Gui-ping
    Qin, Yuan
    Dai, Xiao-yan
    Yu, Xi-yong
    Wu, Xiao-qian
    ACTA PHARMACOLOGICA SINICA, 2023, 44 (02) : 321 - 331